🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This two-phase study aims to explore ways to predict who will respond well ...
Status
Terminated
Location
Columbia University Medical Center
Start Date
2018-01-03
Trial ID
NCT03353220
The purpose of this study is to assess the weight loss effect of lorcaserin...
Status
Completed
Location
Arena Pharmaceuticals, Inc.
Start Date
2007-12
Trial ID
NCT00603291
Treatments Being Tested
A Randomized Phase II study Comparing Lorcaserin versus Duloxetine for the ...
Status
Unknown
Location
Cancer Treatment Centers of America - Atlanta
Start Date
2019-06
Trial ID
NCT03812523
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Status
Completed
Location
Advanced Cardiovascular, LLC
Start Date
2014-01-24
Trial ID
NCT02019264
Treatments Being Tested
Heavy-drinking smokers, including those with alcohol use disorder (AUD), ar...
Status
Terminated
Location
The Mind Research Network
Start Date
2019-10-25
Trial ID
NCT04396847
Treatments Being Tested
Purpose: The purpose of this study is to test new pharmacologic strategies ...
Status
Terminated
Location
Augusta University
Start Date
2016-09
Trial ID
NCT02796144
Treatments Being Tested
The purpose of this study is to assess the safety and weight loss effect of...
Status
Terminated
Location
Bengbu Medical College First Affiliated Hospital
Start Date
2019-09-17
Trial ID
NCT03720574
Treatments Being Tested
The purpose of this study is to assess the weight loss effect of lorcaserin...
Status
Completed
Location
Arena Pharmaceuticals, Inc.
Start Date
2006-11
Trial ID
NCT00395135
Treatments Being Tested
In smokers who are motivated to stop smoking, treatment with lorcaserin com...
Status
Completed
Location
Pharmacology Research Institute
Start Date
2014-03
Trial ID
NCT02044874
Treatments Being Tested
The fixed-dose combination of naltrexone 8mg and bupropion 90mg extended-re...
Status
Completed
Location
Currax Pharmaceuticals
Start Date
2014-09
Trial ID
NCT06090461